Clinical Trial Update: Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin [EARLY_Phase 1]

View source ↗

Summary

A Phase Early 1 trial evaluating anti-Xa level monitoring in surgery patients on fixed-dose heparin has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Venous Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Snippet

Sponsor: University of Utah | Conditions: Deep-Venous Thrombosis, Pulmonary Embolism | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-06-24